Healthcare - Biotechnology - NASDAQ - US
$ 0.0001
0 %
$ 3.07 K
Market Cap
0.0
P/E
INCOME STATEMENT
633 K
REVENUE
-12 M
OPERATING INCOME
-18 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Comera Life Sciences Holdings, Inc.
| Revenue | 633 K |
| Cost Of Revenue | 210 K |
| Gross Profit | 423 K |
| Operating Expenses | 12.4 M |
| Operating Income | -12 M |
| Other Expenses | 6.03 M |
| Net Income | -18 M |
Income Statement
Millions
| Dec-2022 | Dec-2021 | Dec-2020 | |
|---|---|---|---|
| REVENUE | |||
| Revenue | 0.6 | 0.3 | 0.4 |
| GROSS PROFIT | |||
| Cost Of Revenue | 0.2 | 0.2 | 0.1 |
| Gross Profit | 0.4 | 0.2 | 0.3 |
| OPERATING INCOME | |||
| Operating Expenses | 12.4 | 5.7 | 2.5 |
| Selling, General and Administrative Expenses | 10.7 | 3.9 | 1.2 |
| Research and Development Expenses | 1.7 | 1.8 | 1.3 |
| Operating Income | (12.0) | (5.5) | (2.1) |
| PRE-TAX INCOME | |||
| Interest Income Expense | 20.4 K | 0 | 0 |
| Total Other Income | (6.0) | 83.8 K | 2.03 K |
| Pre-Tax Income | (18.0) | (5.5) | (2.1) |
| NET INCOME | |||
| Tax Provision | 0 | (0.2) | (0.1) |
| Net Income | (18.4) | (5.3) | (2.1) |
| EPS | 1.76 | 0.28 | 0.11 |